The FDA has authorized a first-of-its-kind therapeutic device that delivers tumor-treating fields for adults with locally advanced pancreatic cancer. The approval offers a new non-invasive option to extend...
Novel therapies are reshaping how clinicians think about triglyceride management and residual cardiovascular risk. This quick quiz tests your knowledge of the emerging data on APOC3 inhibition and its...
A longitudinal analysis from the Western Australian Raine Study evaluated whether polycystic ovary syndrome coexisting with metabolic dysfunction–associated steatotic liver disease during adolescence is...
Clinical experience continues to document the real-world use of an FDA-approved treatment for seizures associated with specific, hard-to-treat forms of epilepsy. In this new case study, David Burdette, MD, explains how optimization of anti-seizure medications helped an adult patient with hard-to-treat epilepsy achieve improvements in seizure control. Read more.
Lisa Jones, MA, RDN, LDN, FAND; Grace A. Derocha, MBA, RD, CDCES
In part two of this four-part series, Lisa Jones, MA, RDN, LDN, FAND, and Grace A. Derocha, MBA, RD, CDCES, registered dietitian and a certified diabetes care and education specialist, discuss how...
From medication access to adherence challenges, social vulnerability can shape diabetes outcomes. In this expert Q&A, Dr. Mary Elizabeth Patti reviews evidence showing that metabolic surgery delivers...
In this Consultant360 interview, Brian Bergmark, MD explains how olezarsen, an RNA-targeted therapy targeting APOC3, may help address residual cardiovascular risk in patients with moderate...
Lisa Jones, MA, RDN, LDN, FAND; Grace A. Derocha, MBA, RD, CDCES
In part one of this four-part series, Lisa Jones, MA, RDN, LDN, FAND, and Grace A. Derocha, MBA, RD, CDCES, registered dietitian and a certified diabetes care and education specialist, discuss the latest...
In part two of this four-part series, Lisa Jones, MA, RDN, LDN, FAND, and dietitian Ashley Koff, RD, discuss sustainable habits for patients using GLP-1 medications and support for patient transitioning off...
William J. Austin; Sofia M. Ruiz-Castaneda, MD; Riti Kotamarti, MD; Rama Thyagarajan, MD, MPH, CIC; Kristin Mondy, MD; Veena Patel, MD
In this case series, the authors present two cases of disseminated Ureaplasma spp infections in patients with iatrogenic hypogammaglobulinemia due to rituximab therapy. After diagnostic delays, both...
A 21-year-old previously healthy woman presented to the emergency room with a progressive rash on her right leg and was found to be febrile and hypotensive.
Michael Underhill, DO; Sandip Raj Pradhan, MBBS; Jesse D. Bracamonte, DO; Michael Bryan, MD; Nick Allen, MD; Gretchen Anderson, APRN, FNP, MSN
Grip strength is a well-established marker of overall health, functional status, and mortality risk, yet its role in routine ambulatory care remains unclear. This study evaluated the feasibility of...
A 32-year-old woman with a past medical history of anemia and a significant trauma history presented to the hospital in March 2025 with subacute progressive isolation, anorexia, audiovisual hallucinations,...
